Author Archives: Megan Thomas

#Drug development #Investment #Life sciences #Treehill Partners #US government

Expert opinion on life sciences in a Trump/RFK era

Max Baumann, Co-Founder and Head of Execution of Treehill Partners, discusses what investors, drug developers, and the rest of the life science sector can do to prepare for the Trump/RFK era. The arrival of a new US administration generates significant industry-wide speculation and anticipation regarding new policies and agendas that may… Read More

#Business & Investment #Exclusive Content #Opinion

#Antibiotics #Autoimmune disease #Genetics / genomics #Oncology #Painkillers #T cell engagers

New DDW Highlights podcast: 25 November 2024

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week’s most exciting news stories all represent innovative solutions to the… Read More

#News

#DDW Highlights podcast

DDW Highlights: 25 November 2024

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week’s most exciting news stories all represent innovative solutions… Read More

#Podcasts

Woman tests blood glucose level
#AdipoPharma #Biotech #Clinical trials #France #Funding #Type 2 diabetes

Investments pave way for type 2 diabetes breakthrough 

French biotech AdipoPharma is developing a novel and promising type 2 diabetes drug, for which it has successfully secured the funding needed to begin Phase I clinical trials. The company expects to begin clinical trials in the US in mid-2025.     This funding will enable AdipoPharma to accelerate… Read More

#News

Bispecific antibodies
#Antibodies #Antibody engineering #Bispecific Antibodies #EpiBiologics #PEGS Europe

Data shows disease-selective extracellular protein degradation 

EpiBiologics presented new data demonstrating the unique capabilities of its EpiTAC platform at the 16th Annual PEGS Europe conference (November 5-7, 2024 in Barcelona, Spain) and the 2024 Antibody Engineering and will be presenting again at Therapeutics US conference (December 15-18, 2024 in San Diego, California).  … Read More

#News

#Collaboration #Genomics #Genomics England #NHS #Public health #Research #Revvity

Collaboration to advance UK genomics research 

Revvity has announced an expansion of its working relationship with Genomics England that leverages both organisations’ expertise and resources to advance critical genomic initiatives across the United Kingdom.   Building on the parties’ long and productive work history, this collaboration is dedicated to accelerating Genomics England’s research programmes,… Read More

#Business & Investment #News

GBP pound sterling funding
#Antibiotic resistance #Antimicrobial resistance (AMR) #Financing #Funding #Glox Therapeutics

£1 million PACE grant to accelerate precision antibiotics 

Glox Therapeutics has secured £1 million in grant funding from Pathways to Antimicrobial Clinical Efficacy (PACE), one of the UK’s largest public-private initiatives targeting early-stage antimicrobial medicines and diagnostic discovery.   The funding will help to accelerate the development of Glox Therapeutics’ novel antibiotics targeting drug-resistant pathogenic… Read More

#Business & Investment #News

Pancreatic cancer
#Cancer research #iOnctura #Pancreatic cancer #Tumours

Breaking barriers in pancreatic cancer

World Pancreatic Cancer Day takes place on 21 November to raise awareness about pancreatic cancer, support patients and their families, and advocate for increased research and early detection of this deadly disease. iOnctura’s Chief Medical Officer Michael Lahn discusses how we can fight the disease by breaking the defensive wall… Read More

#Cancer Research #Exclusive Content

#Bill & Melinda Gates Foundation #Export and Investment Fund of Denmark (EIFO) #Financing #Freya Biosciences #Women's health

Over $10.4 million invested in women’s and infant health drug 

Women’s health biotech Freya Biosciences has received a $10.4 million strategic investment from the Bill & Melinda Gates Foundation with $1.4 million additional financing from current investor Export and Investment Fund of Denmark (EIFO).  The funds will be used to develop microbial immunotherapies for the treatment of… Read More

#Business & Investment #News

#Events #Gain Therapeutics #Neuroscience 2024 #Parkinson's #Society for Neuroscience

Vodcast: Joanne Taylor, Gain Therapeutics, at Neuroscience 2024

At the Society for Neuroscience’s annual meeting, Neuroscience 2024, which took place in October 2024 in Chicago, DDW’s Megan Thomas met with Joanne Taylor, Senior Vice President of Research at Gain Therapeutics. Read More

#Videos

Downing Street, London, UK
#ABPI #Association of the British Pharmaceutical Industry #Life sciences #NHS #The King's Fund #UK government

Strong leadership needed for UK life sciences industry success

Health and care researchers at The King’s Fund are calling for the UK government and national NHS leaders to play a greater role in developing guidance and providing leadership of health service partnerships with the life sciences industry.   The UK has a large and thriving life… Read More

#News

European map
#Europe #European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) #European Laboratory Day #Events #Lab automation

European Laboratory Day celebrates lab medicine contributions 

The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) hosted European Laboratory Day on 5 November 2024. This annual event promotes activities that highlight the essential role of laboratory medicine in public health, individual patient care, education and research.  Healthcare is a top priority for Europe, as… Read More

#News

#Cancer immunotherapy #Events #Immunotherapy #Oncology

New DDW Highlights podcast: 18 November 2024

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the Society for Immunotherapy of Cancer (SITC) 2024 taking place in Houston… Read More

#News

#DDW Highlights podcast

DDW Highlights: 18 November 2024

The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the Society for Immunotherapy of Cancer (SITC) 2024 taking place… Read More

#Podcasts

Corporate collaboration
#Bio-Rad Laboratories #Drug discovery #ELRIG #Flow Cytometry #From the top

From the Top: Richard Cuthbert, Bio-Rad Laboratories

DDW’s Megan Thomas shines a spotlight on Richard Cuthbert, Global Product Manager at Bio-Rad Laboratories. This interview took place while attending ELRIG Drug Discovery 2024 in London, UK.  MT: What has your career path looked like? Were there any key moments or milestones that led you to where you are today?… Read More

#Business & Investment #Exclusive Content